http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2593638-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_67f8f7c227a5280128c81dad369fdf44 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0028 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-22 |
| filingDate | 2005-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1d9c999bb7f02a0554de97f60bc95c0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a34f65cea6d834a91ae6b2125941766a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b909a673bfd34f1ee514f9bb01b8540e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_426020b03d8076f48d320b7423ef7b18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c31c37fb6c4fe6fce7948196ccf46a9a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db4305dc1a10babf1d53b5d77dd5b61e |
| publicationDate | 2006-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2593638-A1 |
| titleOfInvention | Enhancement agent for high intensity focused ultrasound treatment and method for screening the same |
| abstract | A adjuvantfor high-intensity focused ultrasound (HIFU) therapy, which is a material administrated to the patient prior to the HIFU therapy and can decrease the EEF in the target region of the HIFU therapy, wherein the EEF=nPt/V (in J/mm3) meaning the ultrasonic energy required for the unit volume of turmor which the HIFU can effectively treat, and wherein n= 0.7; P is the gross sound power (in w) of the HIFU source; t is the cumulative time (in s) of the HIFU therapy, and V is the damaged tissue volume (in mm3) caused by the HIFU. The EEF of the target regions that don't accept the adjuvant is defined as EEF (baseline), and the EEF of the regions that accept the adjuvant is defined as EFF(measure), and the ratio of EEF (baseline) /EFF (measure) is greater than 1, preferably 2, and more preferably 4. The adjuvant makes it possible to treat the tumor in deep region and to conduct HIFU therapy for the patient suffering from liver tumor without the excision of rib. It also provides a method of increasing the energy deposition of the target region when conducting HIFU and a method of screening the adjuvant of the HIFU. |
| priorityDate | 2005-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 66.